Loading…

Loading grant details…

Active HORIZON European Commission

Condensates at Membrane Scaffolds – Integrated Systems as Synthetic Cell Compartments


Funder European Commission
Recipient Organization Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften Ev
Country Germany
Start Date Nov 01, 2024
End Date Oct 31, 2028
Duration 1,460 days
Number of Grantees 30
Roles Participant; Associated Partner; Coordinator
Data Source European Commission
Grant ID 101168939
Grant Description

ComeInCell will establish a novel integrated Synthetic Cell platform to provide cost- and resource-efficient, environmentally friendly, widely applicable and quantitative model systems to elucidate key cellular mechanisms of health and disease based on the integration of condensate and membrane models.

Understanding membrane-condensate interactions is vital for deciphering their functional roles in cellular processes. Our consortium employs synthetic vesicles as model systems to explore these interactions.

These tailor-made mimics of cellular compartments offer a platform for studying membrane dynamics and the impact of compartmentalization on the activity of reaction networks and the assembly of complex machinery.

We will design synthetic cells as life-science prototyping tools to decipher the role of membrane-associated condensates in essential cellular processes linked to membrane transport, membrane transformation, metabolic networks, and repair.

The network will confront global challenges, providing solutions in drug development, therapeutics, green-related issues, and synthetic biology.

Our goal is to equip junior scientists with cross-disciplinary expertise for developing integrated synthetic cellular testbeds encompassing condensates and membranes, revolutionizing prototyping systems.

We will train the next generation of biophysicists, biochemists and bioengineers in rigorous quantitative and mechanistic thinking, while establishing strong ties to young and emerging European SMEs in the health sector for efficient dissemination towards new therapies

All Grantees

Institute of Science and Technology Austria; Heinrich-Heine-Universitaet Duesseldorf; Ionera Technologies Gmbh; Ludwig-Maximilians-Universitaet Muenchen; Universita Degli Studi Di Siena; The Chancellor Masters and Scholars of the University of Cambridge; Imperial College of Science Technology and Medicine; Refeyn Gmbh; Md Use Innovations Sl; Stichting Radboud Universiteit; Ecole Normale Superieure de Lyon; Kobenhavns Universitet; Nanion Technologies Gmbh; Universidad de Santiago de Compostela; Springer Nature Ag & Co. Kgaa; Agencia Estatal Consejo Superior de Investigaciones Cientificas; Universidad Complutense de Madrid; Inm - Leibniz-Institut Fuer Neue Materialien Gemeinnuetzige Gmbh; Universitaet Potsdam; Tel Aviv University; Rijksuniversiteit Groningen; Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften Ev; Centre National de la Recherche Scientifique CNRS; Katholieke Universiteit Leuven; University of Surrey; Stichting Nederlandse Wetenschappelijk Onderzoek Instituten; The Company of Biologists Ltd; Technische Universiteit Delft; Dewpoint Therapeutics Gmbh; Universitat Des Saarlandes

Advertisement
Apply for grants with GrantFunds
Advertisement
Browse Grants on GrantFunds
Interested in applying for this grant?

Complete our application form to express your interest and we'll guide you through the process.

Apply for This Grant